lysophosphatidic acid has been researched along with Cholangitis, Sclerosing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, T; Satoh, T | 1 |
| Barbier, O; Krawczyk, M; Kremer, AE; Lammert, F; Milkiewicz, M; Milkiewicz, P; Neurath, MF; Trottier, J; Wunsch, E | 1 |
2 other study(ies) available for lysophosphatidic acid and Cholangitis, Sclerosing
| Article | Year |
|---|---|
Generalized pruritus in primary sclerosing cholangitis: implications of histamine release by lysophosphatidic acid.
Topics: Adolescent; Cholangitis, Sclerosing; Histamine H1 Antagonists, Non-Sedating; Histamine Release; Humans; Lysophospholipids; Male; Pruritus; Terfenadine | 2015 |
Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.
Topics: Adult; Aged; Biomarkers; Cholangitis, Sclerosing; Cholestasis; Cross-Sectional Studies; Female; Humans; Liver Cirrhosis, Biliary; Lysophospholipids; Male; Middle Aged; Phosphoric Diester Hydrolases; Prognosis; Proportional Hazards Models; Prospective Studies; Pruritus; Quality of Life; Severity of Illness Index; Survival Analysis; Young Adult | 2016 |